Performance Sleep, Performance Dose 20 units (1mg Tesamorelin / 200mcg Ipamorelin) Frequency 5 days / week Administration Subcutaneous Timing PM, 60-90 minutes after last meal, close to bedtime Vial Size 12mg (10mg Tesamorelin / 2mg Ipamorelin) Reconstitution 2mL Bacteriostatic Water Cycle Length 3 months on, 2 months off Vials / Month 2 Vials / Cycle 6 Do not combine with other GH-stimulating peptides such as CJC-1295/Ipamorelin
This allows your body to adjust to the increased antioxidant support and the detoxification processes it may stimulate
Regulatory status: Not approved for human use by any regulatory agency
BPC-157 Oral Dosage: When Troches or Capsules Make Clinical Sense Oral BPC-157 is preferred for gastrointestinal indications including leaky gut, inflammatory bowel conditions, and systemic anti-inflammatory support where localized injection is not the primary target
Vin ung h tr lm du da b kch ng, gim vim v mn, ng thi h tr iu tr cc vn v da khc nh nm, tn nhang, thm sm
Circulating Fe 3+ enters cells with the assistance of transferrin and subsequently converts to Fe 2+ ( 2+ can catalyze the generation of metabolically toxic reactive oxygen species and phospholipid peroxide through the Fenton reaction, leading to cell damage or death (Figure 4)